SITEMAP Email: support@aastocks.com AASTOCKS.COM LIMITED (阿斯達克網絡信息有限公司) All rights reserved. Disclaimer You expressly agree that the use of this app/website is at your sole risk. AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co. Ltd, Nasdaq, Inc., their respective holding companies and/or any subsidiaries of ...
SITEMAP Email: support@aastocks.com AASTOCKS.COM LIMITED (阿斯達克網絡信息有限公司) All rights reserved. Disclaimer You expressly agree that the use of this app/website is at your sole risk. AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co. Ltd, Nasdaq, Inc., their respective holding companies and/or any subsidiaries of such holding companies, their Sources and/or other third party data provider(s) endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions. Neither AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co.Ltd., Nasdaq, Inc. nor their respective holding companies and/or any subsidiaries of such holding companies nor their Sources and/or other third party data provider(s) make any express or implied offers, representations or warranties (including, without limitation, any warranty or merchantability or fitness for a particular purpose or use) regarding the Information. Neither AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co. Ltd., Nasdaq, Inc. nor their respective holding companies and/or any subsidiaries of such holding companies nor their Sources and/or other third party data provider(s) will be liable to any Subscriber or any other party for any interruption, inaccuracy, error, or omission, regardless of cause, in the Information or for any damages (whether direct or indirect, consequential, punitive, or exemplary) resulting from its use by any party. AASTOCKS.com Limited shall not be liable for any failure or delay in performance of its obligations under this Disclaimer because of circumstances beyond its ...
SBM Offshore N.V. press release ( SBFFY ): Q1 Revenue of $3.5B. Increase in full year 2026 Directional revenue guidance from around US$6.5 billion to above US$6.9 billion Full year 2026 Directional EBITDA baseline guidance maintained around US$1.8 billion FEED contract award by ExxonMobil Guyana for the Longtail development project Two new Fast4Ward® MPF hulls ordered, driven by strong FPSO market...
SBM Offshore N.V. press release ( SBFFY ): Q1 Revenue of $3.5B. Increase in full year 2026 Directional revenue guidance from around US$6.5 billion to above US$6.9 billion Full year 2026 Directional EBITDA baseline guidance maintained around US$1.8 billion FEED contract award by ExxonMobil Guyana for the Longtail development project Two new Fast4Ward® MPF hulls ordered, driven by strong FPSO market outlook Cash dividend of US$100 million (equivalent to EUR84 million2 or EUR0.5009 per ordinary share) payable on May 13, 2026 US$270 million (equivalent to EUR227 million3) share repurchase program on track, c. 18% completed4 Inclusion of SBM Offshore in the AEX index in March 2026 More on SBM Offshore N.V. SBM Offshore N.V. 2025 Q4 - Results - Earnings Call Presentation SBM Offshore N.V. (SBFFY) Q4 2025 Earnings Call Transcript SBM Offshore wins FEED contracts from ExxonMobil for Guyana Longtail FPSO project Historical earnings data for SBM Offshore N.V. Dividend scorecard for SBM Offshore N.V.
In recent months, President Donald Trump has taken an increasingly unconventional approach to American business, pursuing measures that some corporate leaders view as alarming - from pushing to cap credit-card interest rates to striking deals that give the government stakes in private companies. Some executives are so worried Trump will ask for a stake in their company that they have prepared for ...
In recent months, President Donald Trump has taken an increasingly unconventional approach to American business, pursuing measures that some corporate leaders view as alarming - from pushing to cap credit-card interest rates to striking deals that give the government stakes in private companies. Some executives are so worried Trump will ask for a stake in their company that they have prepared for Oval Office meetings by rehearsing what they would say to fend off the president’s advances, lobbyists involved in the preparations told the Wall Street Journal . Others welcome Trump’s attention. United Airlines ( UAL ) CEO Scott Kirby appealed to Trump with the idea of creating a “national champion” airline during meetings with Trump and top officials at the White House, people familiar with the discussions said . United asked for regulatory permission to merge with American Airlines ( AAL ), and top Trump aides discussed whether the U.S. should take a stake in what would be one of the biggest airlines in the world, WSJ reported, citing people familiar with the meetings. Trump later said he didn’t support a merger, American Airlines was resistant and United abandoned its bid. The administration talked with Spirit Airlines about providing a loan of up to $500M in return for warrants that would have given the U.S. a significant stake in the low-cost carrier, The Wall Street Journal reported last month. When the company offered 80% in exchange for the government bailout, Trump suggested 90%, according to people familiar with the matter. But Spirit bondholders didn’t want to subordinate their claims to the federal government, according to a person familiar with the matter. The government pulled out of negotiations, and Spirit ( FLYYQ ) shut down Saturday. Administration officials are encouraging the president’s push to exert greater influence over private-sector industries through the White House. The Trump administration has disclosed direct investment stakes in at least 10 ...
Himax Technologies press release ( HIMX ): Q1 GAAP EPADS of $0.046. Revenue of $199M (-7.5% Y/Y). Q1 2026 revenues were $199.0 million, a slight sequential decline of 2.0%, reaching the high end of guidance range of 2.0% to 6.0% decrease QoQ Q1 GM reached 30.4%, at the high end of guidance of flat to slightly down from 30.4% in the previous quarter Q1 2026 after-tax profit was $8.0 million, or 4.6...
Himax Technologies press release ( HIMX ): Q1 GAAP EPADS of $0.046. Revenue of $199M (-7.5% Y/Y). Q1 2026 revenues were $199.0 million, a slight sequential decline of 2.0%, reaching the high end of guidance range of 2.0% to 6.0% decrease QoQ Q1 GM reached 30.4%, at the high end of guidance of flat to slightly down from 30.4% in the previous quarter Q1 2026 after-tax profit was $8.0 million, or 4.6 cents per diluted ADS, exceeding the guidance range of 2.0 to 4.0 cents Himax ( HIMX ) Q2 2026 revenues to increase 10.0% to 13.0% QoQ. GM to be around 32%. Profit per diluted ADS to be in the range of 8.6 cents to 10.3 cents Second Quarter 2026 Guidance Net Revenue: Increase 10.0% to 13.0% QoQ Gross Margin: Around 32%, depending on final product mix Profit: 8.6 cents to 10.3 cents per diluted ADS Click to enlarge More on Himax Technologies Himax Technologies: The Best Is Yet To Come Himax Technologies, Inc. (HIMX) Q4 2025 Earnings Call Transcript Himax Technologies, Inc. 2025 Q4 - Results - Earnings Call Presentation Himax Technologies Q1 2026 Earnings Preview Himax anticipates sales rebound in Q2 2026 as automotive and AI drive growth
Genco Shipping ( GNK ) declares $0.35/share quarterly dividend , -30% decrease from prior dividend of $0.50. Forward yield 5.49% Payable May 26; for shareholders of record May 18; ex-div May 18. See GNK Dividend Scorecard, Yield Chart, & Dividend Growth. More on Genco Shipping Genco Shipping: Freight Rates Offer Hope, But The Cycle Isn't On Your Side Genco Shipping: Why I Don't Expect Further Bids...
Genco Shipping ( GNK ) declares $0.35/share quarterly dividend , -30% decrease from prior dividend of $0.50. Forward yield 5.49% Payable May 26; for shareholders of record May 18; ex-div May 18. See GNK Dividend Scorecard, Yield Chart, & Dividend Growth. More on Genco Shipping Genco Shipping: Freight Rates Offer Hope, But The Cycle Isn't On Your Side Genco Shipping: Why I Don't Expect Further Bids And Why I Favor Cheaper Plays Genco Shipping & Trading Limited (GNK) Q4 2025 Earnings Call Transcript Diana Shipping starts $23.50/share tender offer for Genco Quant check dry bulk shipping names as Baltic Dry Index strength supports sentiment
Earnings Call Insights: Light & Wonder (LNWO) Q1 2026 Management view "Over the past several months, we have faced a number of external headwinds, including tariff pressures and more recently, geopolitical and macroeconomic uncertainty affecting end consumers." (CEO, President & Director Matthew Wilson) "Our recurring revenue, which represented 73% of total consolidated revenue, grew 13% year-over...
Earnings Call Insights: Light & Wonder (LNWO) Q1 2026 Management view "Over the past several months, we have faced a number of external headwinds, including tariff pressures and more recently, geopolitical and macroeconomic uncertainty affecting end consumers." (CEO, President & Director Matthew Wilson) "Our recurring revenue, which represented 73% of total consolidated revenue, grew 13% year-over-year" and "adjusted free cash flow of $207 million in the quarter, up 86% year-over-year." (CEO Wilson) "EPSa or adjusted earnings per share grew 7% to $1.45" and the company flagged that "SciPlay and the social casino industry are seeing some softness." (CEO Wilson) "Revenue grew 3% to $512 million, and AEBITDA increased 7% to $271 million" in Gaming, while "gaming machine sales were down 25% and gaming systems declined 14%" which management said was "largely timing and not demand driven." (CEO Wilson) "Grover delivered $43 million in revenue for the quarter" and "we launched our first Light & Wonder title, Eureka Treasure Train... in Indiana with exceptional early results." (CEO Wilson) "Revenue grew 18% year-over-year to $91 million" in iGaming and "wagers processed... grew 19% year-over-year to a record $29.9 billion." (CEO Wilson) "Consolidated revenue of $790 million was up 2% year-over-year" and "restructuring and other costs were $54 million... inclusive of $50 million of legal reserve contingencies." (EVP, CFO & Treasurer Oliver Chow) Outlook "Subject to external uncertainties, including geopolitical developments and potential regulatory changes, we are forecasting mid- to high single-digit consolidated AEBITDA growth for 2026." (CFO Chow) "We are absorbing approximately $40 million in headwinds... principally U.S. tariffs and the recently enacted U.K. iGaming tax changes" and "we're carrying an estimated $20 million of impact on planned investment spend related to AI infrastructure and new market openings." (CFO Chow) "We remain committed to reducing leverage to ...
JHVEPhoto/iStock Editorial via Getty Images Investment thesis Bausch Health ( BHC ) delivered a good Q1 report, beating market expectations in terms of revenue and net profit. However, the market was not impressed by the high rate of revenue growth, as organic growth turned out to be weaker, and demand for basic products continues to stagnate. I recommended buying Bausch shares in previous article...
JHVEPhoto/iStock Editorial via Getty Images Investment thesis Bausch Health ( BHC ) delivered a good Q1 report, beating market expectations in terms of revenue and net profit. However, the market was not impressed by the high rate of revenue growth, as organic growth turned out to be weaker, and demand for basic products continues to stagnate. I recommended buying Bausch shares in previous articles, as my investment idea was the deleverage of the company. In January, the company carried out refinancing, which improved the repayment schedule, but the debt burden itself has not significantly decreased. The idea is quite risky, and betting on deleveraging may not be justified, so I would recommend that conservative investors stay away from Bausch. If the debt is reduced by at least 20-30%, the shares can grow from $6 to $7-9 with an upside of 15-30%. For more risky investors, I maintain a Buy rating, while I do not recommend holding more than 3% of the portfolio in Bausch shares. Margins Improve While Demand Stagnates I recommend reading my first three articles about Bausch Health, among other things. There, in addition to financial analysis of the reports, I also deeply analyzed the company's business model, described its development strategy, the strengths and weaknesses of this strategy, and the key growth drivers and risks inherent in the company. This will help you gain a deeper understanding of the business and better understand the reasons for the company's current financial situation. And now I will proceed to the analysis of the latest report. Investor Presentation At first glance, it may seem that the company delivered strong results for Q1, but as I delve deeper, I realize that everything is not as good as I would like. That's why I call this investment risky. Revenue increased by 12% yoy to $2.524 billion , with consensus expectations of $2.41 billion, which is 4.8% lower than the actual result . At the same time, of these 12%, only 7% is organic growth, an...
Generate Biomedicines, Inc. press release ( GENB ): Q1 Revenue of $7.22M. Net loss was $61.7 million for the quarter ended March 31, 2026, compared with $44.3 million for the same period in 2025, which includes non-cash stock-based compensation expense of $6.4 million and $4.7 million, respectively. Net cash used in operating activities was $80.4 million for the quarter ended March 31, 2026, compa...
Generate Biomedicines, Inc. press release ( GENB ): Q1 Revenue of $7.22M. Net loss was $61.7 million for the quarter ended March 31, 2026, compared with $44.3 million for the same period in 2025, which includes non-cash stock-based compensation expense of $6.4 million and $4.7 million, respectively. Net cash used in operating activities was $80.4 million for the quarter ended March 31, 2026, compared with $53.2 million for the same period in 2025. More on Generate Biomedicines, Inc. Generate Biomedicines Begins IPO Push With Major Collaboration Deals Largest IPOs of the last 90 days register mixed debut Generate Biomedicines gains buy initiations from Guggenheim, Piper Sandler Historical earnings data for Generate Biomedicines, Inc. Financial information for Generate Biomedicines, Inc.
XH4D/iStock via Getty Images The following segment was excerpted from the Aristotle International Equity ADR WM Q1 2026 Commentary. Headquartered in Hong Kong, Techtronic Industries ( TTNDF )( TTNDY ) (“TTI”) is a global manufacturer of power tools, outdoor power equipment and related accessories. The company operates primarily through two flagship brands: Milwaukee, which serves professional trad...
XH4D/iStock via Getty Images The following segment was excerpted from the Aristotle International Equity ADR WM Q1 2026 Commentary. Headquartered in Hong Kong, Techtronic Industries ( TTNDF )( TTNDY ) (“TTI”) is a global manufacturer of power tools, outdoor power equipment and related accessories. The company operates primarily through two flagship brands: Milwaukee, which serves professional tradespeople, and Ryobi, which targets the DIY and light professional market (including handymen and maintenance professionals whose needs fall between homeowners and full-time trades). Over the past decade, TTI has transformed itself into one of the leading players in the global power tool industry, driven by sustained innovation and disciplined brand investment. Milwaukee has been the primary growth engine, expanding from approximately $450 million in sales in the early 2000s to roughly $10 billion today. The brand has gained meaningful share in professional trades through a focus on productivity, safety and battery-powered innovation. Ryobi remains a leading DIY platform, supported by a long-standing distribution relationship with Home Depot, TTI’s largest retail partner. TTI continues to benefit from the long-term industry transition from corded, gas-powered and pneumatic tools toward battery-powered platforms. The company’s strategy of maintaining backward compatibility across battery generations has reinforced customer loyalty and created a durable installed base across both Milwaukee and Ryobi ecosystems. High-Quality Business Some of the quality characteristics we have identified for TTI include: Leading positions in professional and DIY power tools through the Milwaukee and Ryobi brands, supported by strong brand equity, deep engagement with professional tradespeople and a track record of consistent product innovation; A powerful battery ecosystem strategy, with over 110 million M18 and 65 million M12 batteries in circulation and backward and forward compatibility acro...
loops7/iStock via Getty Images Introduction Our most recent commentary on Ingersoll Rand Inc. ( IR ) was in October of last year, when we rated the US-based industrial player a 'Hold'. Although the stock has experienced significant volatility recently, our 'Hold' rating looks like the right call, given that it continues to trade around $76, the price it was at about 6 months ago. We believe a caut...
loops7/iStock via Getty Images Introduction Our most recent commentary on Ingersoll Rand Inc. ( IR ) was in October of last year, when we rated the US-based industrial player a 'Hold'. Although the stock has experienced significant volatility recently, our 'Hold' rating looks like the right call, given that it continues to trade around $76, the price it was at about 6 months ago. We believe a cautious stance remains the right call in IR going forward. The key to our caution at the time was the breaking of the multi-year trendline at the beginning of calendar 2025. Shares did manage to recover to almost $100 per share but topped out on the release of the company's Q4 earnings for fiscal 2025 on the 12th of February this year. Since then, we have seen a sustained pattern of lower lows, where the subsequent earnings beat in Q1 this year (announced 4/28/2026) has done little to stop the sustained selling pressure in this stock. Suffice it to say, as noted in previous commentary, given the large acquisition spree IR has undertaken in recent times, a pattern of consistent quarterly sales and earnings beats has failed to encourage investor buying, all else being equal. What seems to be carrying more weight among investors is the absence of improving EPS & revenue revisions , especially in light of the company's significant spending in recent times. Concerns on the Technical Chart Suffice it to say, the technicals are stating loud and clear that IR's investment case remains unattractive from a risk/reward basis. This is confirmed by multiple breaches of the multi-year trendlines below. Therefore, let's delve into the company's latest quarterly report and investigate why the company's fundamentals continue to disinterest the investing public post the company's latest quarterly earnings numbers. Ingersoll Rand 7-Year Technicals ( StockCharts ) Q1 Earnings One would have thought that the Non-GAAP EPS beat ($0.77 per share), the almost 8% top-line growth rate (revenues of $1.85...
Gyre Therapeutics press release ( GYRE ): Q1 GAAP EPS of -$0.10. Revenue of $22.5M. As of March 31, 2026, Gyre held $37.5 million in cash and cash equivalents, $12.3 million in short-term bank deposits, and $29.4 million in long-term certificates of deposit, totaling $79.2 million. Compared to $75.9 million as of December 31, 2025, total cash increased by $3.3 million, or 4%, primarily driven by h...
Gyre Therapeutics press release ( GYRE ): Q1 GAAP EPS of -$0.10. Revenue of $22.5M. As of March 31, 2026, Gyre held $37.5 million in cash and cash equivalents, $12.3 million in short-term bank deposits, and $29.4 million in long-term certificates of deposit, totaling $79.2 million. Compared to $75.9 million as of December 31, 2025, total cash increased by $3.3 million, or 4%, primarily driven by higher customer collections and reduced tax payments. More on Gyre Therapeutics Seeking Alpha’s Quant Rating on Gyre Therapeutics Historical earnings data for Gyre Therapeutics Financial information for Gyre Therapeutics
Ministers to mandate use of tools that record individuals’ cumulative exposure to harrowing incidents Policing in England and Wales faces a reckoning over the levels of trauma experienced by officers and staff as “trauma tracker” tools are to be mandated by ministers to ensure the psychological toll caused by exposure to death, abuse and neglect is recorded. A Home Office white paper published in ...
Ministers to mandate use of tools that record individuals’ cumulative exposure to harrowing incidents Policing in England and Wales faces a reckoning over the levels of trauma experienced by officers and staff as “trauma tracker” tools are to be mandated by ministers to ensure the psychological toll caused by exposure to death, abuse and neglect is recorded. A Home Office white paper published in January outlined a legislative push to make trauma monitoring systems mandatory across all 43 forces in England and Wales. Continue reading...
Cascades press release ( CADNF ): Q1 Non-GAAP EPS of $0.07. Revenue of $1.12M. Operating income of $81 million (compared with $76 million in Q4 2025 and $50 million in Q1 2025); Net debt1 of $1,901 million as of March 31, 2026 (compared with $1,896 million as of December 31, 2025). Net debt to EBITDA ( A ) ratio1 remained stable at 3.3x; Total capital expenditures of $28 million in Q1 2026, compar...
Cascades press release ( CADNF ): Q1 Non-GAAP EPS of $0.07. Revenue of $1.12M. Operating income of $81 million (compared with $76 million in Q4 2025 and $50 million in Q1 2025); Net debt1 of $1,901 million as of March 31, 2026 (compared with $1,896 million as of December 31, 2025). Net debt to EBITDA ( A ) ratio1 remained stable at 3.3x; Total capital expenditures of $28 million in Q1 2026, compared to $42 million in Q4 2025 and $36 million in Q1 2025. The Corporation's 2026 forecasted capital expenditures before disposals will be in a range of $150 million to $175 million. More on Cascades Inc. Cascades Inc. (CAS:CA) Q4 2025 Earnings Call Transcript Cascades Inc. 2025 Q4 - Results - Earnings Call Presentation Containerboard leads as forest products sector faces mixed Q1 earnings: RBC Capital Cascades trims Q1 EBITDA range to $115M–$120M; reaffirms 2026 profit goal Historical earnings data for Cascades Inc.